Clinical outcomes of VNS therapy with AspireSR® (including cardiac-based seizure detection) at a large complex epilepsy and surgery centre

•AspireSR® responds on-demand to ictal tachycardia associated with ∼80% of seizures.•Newly inserted AspireSR® resulted in 59% of patients achieving ≥50% improvement at 13 months.•Battery change to AspireSR® offered 71% of patients ≥50% benefit at mean 21 months.•AutoStim renders VNS therapy independ...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Seizure (London, England) England), 2018-05, Vol.58, p.120-126
Hauptverfasser:	Hamilton, Preci, Soryal, Imad, Dhahri, Prince, Wimalachandra, Welege, Leat, Anna, Hughes, Denise, Toghill, Nicole, Hodson, James, Sawlani, Vijay, Hayton, Tom, Samarasekera, Shanika, Bagary, Manny, McCorry, Dougall, Chelvarajah, Ramesh
Format:	Artikel
Sprache:	eng
Schlagworte:	AspireSR Automatic stimulation (AutoStim) Cardiac-based seizure detection (CBSD) Pharmacoresistant epilepsy Vagal nerve stimulation (VNS)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!